- Novo A/S participated in 7 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $1,555,405,416 (averaging $222,200,774 per round).
- Menlo Therapeutics: Venture capital (Series C) ($50M)
- E-Scape Bio: Venture capital (Series A) ($63M)
- Cirius Therapeutics: Venture capital (Series A) ($40M)
- Frazier Healthcare Partners
- Novartis Venture Fund
Want to see the complete list?